During the second wave in India, one in seven COVID patients were hospitalized, higher than the western world where cumulatively 5 to 10 per cent of Covid positive patients have been hospitalized.
In Delhi, a new complication of mucormycosis or black fungal infection infecting the lower intestine of two patients has been detected.
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Rogue antibodies wreak havoc in severe COVID-19 cases